I want to know the answer to the following question:
Who put out a report in 2012?
All the background I'm provided with is that "Others have argued that excessive regulation suppresses therapeutic innovation, and that the current cost of regulator-required clinical trials prevents the full exploitation of new genetic and biological knowledge for the treatment of human disease.". Is that enough to answer the question?